Search - tctmd.com

Displaying 181 - 200 of 379

Sort: Relevancy | Date

Presentation TCT 2019

Virtue® SEB: Promising Data for Innovative LIMUS Delivery

Presenter: Juan Granada

September 26, 2019

Presentation TCT 2019

Potential Hazards of Re-Stenting

Presenter: David Kandzari

September 26, 2019

Presentation TCT 2019

TCT 46: FANTOM II trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – First Report on Initial 48 Month Outcomes

Presenter: Alexandre Abizaid

September 25, 2019

Presentation TCT 2019

TCT 43: A Prospective Randomized Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects with up to two de novo Coronary Artery Lesions – BIOFLOW IV: 4 Years Clinical Results

Presenter: Bernhard Witzenbichler

September 25, 2019

Presentation TCT 2019

TCT 41: A prospective multicentre randomized all-comers trial to assess the safety and effectiveness of the ultra-thin-strut sirolimus-eluting coronary stent Supraflex: 2-year results of the TALENT trial

Presenter: Azfar Zaman

September 25, 2019

News Conference News ESC 2019

BIOSTEMI: Ultrathin-Strut Orsiro Superior to Xience for 1-Year TLF After Primary PCI

Caitlin E. Cox

September 10, 2019

News Industry News

SINOMED® Concludes Enrollment of the PIONEER III Randomized, Pivotal Study of the BuMA Supreme® Coronary Drug-Eluting Stent

July 23, 2019

News Industry News

SMT Announces CE* Mark for the Most Deliverable Stent Supraflex Cruz

July 11, 2019

News Conference News EuroPCR 2019

Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years

Michael O'Riordan

May 27, 2019

News Industry News

Latest generation DES: ANGIOLITE trial 24-month outcomes revealed at EuroPCR 2019 the non-inferiority of angiolite vs the gold standard EES

May 23, 2019

News Conference News EuroPCR 2019

Firehawk Stent Still Holds Up Well to Xience at 2 Years: TARGET All Comers

Caitlin E. Cox

May 23, 2019

News Conference News EuroPCR 2019

Ultrathin Struts Show Strength in Small Vessels: BIO-RESORT at 3 Years

Caitlin E. Cox

May 21, 2019

Presentation EuroPCR 2019

Clinical outcome of a novel sirolimus-coated balloon in patients with coronary artery disease EASTBOURNE registry-interim analysis LBCT session

Presenter: Bernardo Cortese

May 21, 2019

News Industry News

Concept Medical Inc. Granted "Breakthrough Device Designation" From FDA for Its MagicTouch Sirolimus Coated Balloon

May 02, 2019

Presentation CIT 2019

A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Scaffold in Patients with Coronary Artery Disease (FUTURE-I) 3-Year Clinical and Imaging Outcomes

Presenter: Bo Xu

March 29, 2019

Presentation CIT 2019

New Drug-Coated Balloon Technologies: Limus and Beyond

Presenter: Bruno Scheller

March 28, 2019

Presentation CIT 2019

DESSOLVE C: A Randomized Multi-Center Controlled Trial Comparing 2 Biodegradable Polymer-Coated Sirolimus-Eluting Stents in Patients with Coronary Artery Disease

Presenter: Bin Wang, Yaling Han

March 28, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for February 2019

Shelley Wood

March 01, 2019

News Daily News

FDA Approves Orsiro Ultrathin-Strut Stent for CAD

Michael O'Riordan

February 22, 2019

Presentation JIM 2019

12 months results of First-In-Man study with coronary dedicated bifurcation cobalt-chromium sirolimus-eluting stent BiOSS LimC

Presenter: Robert J. Gil

February 15, 2019

Advertisement

Virtue® SEB: Promising Data for Innovative LIMUS Delivery

Potential Hazards of Re-Stenting

TCT 46: FANTOM II trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – First Report on Initial 48 Month Outcomes

TCT 43: A Prospective Randomized Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects with up to two de novo Coronary Artery Lesions – BIOFLOW IV: 4 Years Clinical Results

TCT 41: A prospective multicentre randomized all-comers trial to assess the safety and effectiveness of the ultra-thin-strut sirolimus-eluting coronary stent Supraflex: 2-year results of the TALENT trial

BIOSTEMI: Ultrathin-Strut Orsiro Superior to Xience for 1-Year TLF After Primary PCI

SINOMED® Concludes Enrollment of the PIONEER III Randomized, Pivotal Study of the BuMA Supreme® Coronary Drug-Eluting Stent

SMT Announces CE* Mark for the Most Deliverable Stent Supraflex Cruz

Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years

Latest generation DES: ANGIOLITE trial 24-month outcomes revealed at EuroPCR 2019 the non-inferiority of angiolite vs the gold standard EES

Firehawk Stent Still Holds Up Well to Xience at 2 Years: TARGET All Comers

Ultrathin Struts Show Strength in Small Vessels: BIO-RESORT at 3 Years

Clinical outcome of a novel sirolimus-coated balloon in patients with coronary artery disease EASTBOURNE registry-interim analysis LBCT session

Concept Medical Inc. Granted "Breakthrough Device Designation" From FDA for Its MagicTouch Sirolimus Coated Balloon

A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Scaffold in Patients with Coronary Artery Disease (FUTURE-I) 3-Year Clinical and Imaging Outcomes

New Drug-Coated Balloon Technologies: Limus and Beyond

DESSOLVE C: A Randomized Multi-Center Controlled Trial Comparing 2 Biodegradable Polymer-Coated Sirolimus-Eluting Stents in Patients with Coronary Artery Disease

TCTMD’s Top 10 Most Popular Stories for February 2019

FDA Approves Orsiro Ultrathin-Strut Stent for CAD

12 months results of First-In-Man study with coronary dedicated bifurcation cobalt-chromium sirolimus-eluting stent BiOSS LimC

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content